Skip to main content
. 2011 Mar 8;6(3):e17781. doi: 10.1371/journal.pone.0017781

Table 2. Exposures and potential risk factors for acute hepatitis C; bold if included in multivariable analysis.

Category Subcategory Cases (%) Controls (%) Univariable Multivariable
OR (95%- CI) p Adj. OR (95%- CI) p
N 34 (100.0) 67 (100.0)
Sexual behaviour in the previous 12 months
Number of sex partners More than 10 22 (64.7) 33 (49.3) 1.89 (0.81–4.42) 0.204 0.939
More than 20 17 (50.0) 27 (40.3) 1.48 (0.65–3.40) 0.400 0.641
More than 50 7 (20.6) 13 (19.4) 1.08 (0.39–3.01) 1.000
Anonymous sex partners More than 50 per cent 16 (47.1) 30 (44.8) 1.10 (0.48–2.51) 0.836
Sex frequency Twice weekly or more 9 (26.5) 17 (25.4) 1.06 (0.41–2.71) 1.000
Met sex partners through the internet Often or always 18 (52.9) 26 (38.8) 1.77 (0.77–4.08) 0.206
Met sex partners in saunas Often or always 5 (14.7) 9 (13.4) 1.11 (0,34–3.62) 1.000
Met sex partners at sex parties Often or always 10 (29.4) 12 (17.9) 1.91 (0.73–5.02) 0.209
Met sex partners at leather venues Often or always 8 (23.5) 8 (11.9) 2.27 (0.77–6.70) 0.155
Insertive AI § with non-steady partners Frequently or always 21 (61.8) 24 (35.8) 2.89 (1.23–6.79) 0.019 0.347
Receptive AI § with non-steady partners Frequently or always 20 (58.8) 26 (38.8) 2.25 (0.97–5.23) 0.062 0.759
BDSM §§ or fisting with non-steady partners Frequently or always 10 (29.4) 9 (13.4) 2.69 (0.97–7.44) 0.063 0.708
UAI with non-steady partners * One episode or more 22 (64.7) 25 (37.3) 3.08 (1.30–7.28) 0.012 0.288
Five episodes or more 15 (44.1) 14 (20.9) 2.99 (1.22–7.33) 0.020 0.653
STIs and condom attitudes
History of syphilis In the last 12 months 10 (29.4) 9 (13.4) 2.69 (0.97–7.44) 0.063 0.192
History of Chlamydia infection In the last 12 months 7 (20.6) 10 (14.9) 1.48 (0.51–4.30) 0.575
History of gonorrhoea In the last 12 months 8 (23.5) 12 (17.9) 1.41 (0.51–3.87) 0.599
History of any of the three above In the last 12 months 19 (55.9) 21 (31.3) 2.78 (1.18–6.50) 0.020 0.211
Non-steady partners with syphilis In the last 12 months 5 (14.7) 10 (14.9) 0.98 (0.31–3.14) 1.000
Non-steady partners with HIV Presently 27 (79.4) 38 (56.7) 2.94 (1.13–7.70) 0.029 0.986
Would engage in UAI if sex partner is seroconcordant for HIV 22 (64.7) 39 (58.2) 1.32 (0.56–3.09) 0.667
Would never engage in any UAI 4 (11.8) 22 (32.8) 0.27 (0.09–0.87) 0.029 0.296
Condoms not considered for prevention of STIs (other than HIV) 14 (41.2) 13 (19.4) 2.91 (1.17–7.24) 0.031 0.554
Sexual exposures since 2000
UAI* with person known to be HCV positive 3 (8.8) 5 (7.5) 1.20 (0.27–5.35) 1.000
Group sex Yes 31 (91.2) 44 (65.7) 5.40 (1.49–19.58) 0.007 3,50 (0.84–14.52) 0.084
Frequently or always 15 (44.1) 14 (20.9) 3.00 (1.22–7.33) 0.020 0.786
PDE-5 inhibitors ** Frequently or always 15 (44.1) 12 (17.9) 3.62 (1.44–9.09) 0.008 0.557
Nitrite inhalants or large amounts of alcohol Frequently or always 22 (64.7) 36 (53.7) 1.58 (0.67–3.70) 0.395
Dilative sex toys Usage 27 (79.4) 37 (55.2) 3.13 (1.20–8.17) 0.028 0.588
Frequently sharing dilative sex toys 3 (8.8) 2 (3.0) 3.15 (0.50–19.80) 0.332
Anal pain with bloody diarrhoea Repeatedly 6 (17.6) 4 (6.0) 3.38 (0.88–12.91) 0.082 0.384
Rectal trauma with bleeding Frequently or always 7 (20.6) 3 (4.5) 5.53 (1.33–23.00) 0.029 6.19 (1.17–32.81) 0.032
Skin damage (BDSM§§) with bleeding Yes 8 (23.5) 9 (13.4) 1.98 (0.69–5.72) 0.261
Receptive fisting Yes 17 (50.0) 15 (22.4) 3.47 (1.43–8.39) 0.007
Frequently or always 12 (35.3) 6 (9.0) 5.55 (1.86–16.57) 0.002
Frequent receptive fisting without gloves (or gloves shared) 11 (32.4) 4 (6.0) 7.53 (2.18–26.03) 0.001 5.71 (1.50–21.68) 0.011
Frequent receptive fisting and sharing of lubricant 10 (29.4) 5 (7.5) 5.17 (1.60–16.69) 0.006 0.603
Nosocomial exposures
Blood or plasma transfusion Any before 1991 2 (5.9) 5 (7.5) 0.78 (0.14–4.22) 1.000
Major surgery Repeatedly 11 (32.4) 11 (16.4) 2.44 (0.93–6.40) 0.079 0.507
Major dental treatment Repeatedly 2 (5.9) 10 (14.9) 0.36 (0.07–1.73) 0.329
Endoscopies (gastro-, colono-, cystoscopies) Repeatedly 13 (38.2) 23 (34.3) 1.18 (0.50–2.79) 0.826
Acupuncture Repeatedly 2 (5.9) 5 (7.5) 0.78 (0.14–4.22) 1.000
Other exposures since 2000
Tattooing Repeatedly 4 (11.8) 9 (13.4) 0.86 (0.24–3.02) 0.812
Body-piercing Repeatedly 7 (20.6) 5 (7.5) 3.22 (0.94–11.04) 0.099 0.529
Imprisonment More than 72 h 0 (0.0) 2 (3.0) 0.549
Shared household with HCV positive person 4 (11.8) 5 (7.5) 1.60 (0.40–6.40) 0.489
Consumption of NADs *** Yes 28 (82.4) 35 (52.2) 4.27 (1.56–11.64) 0.004 3,25 (1.06–9.96) 0.040
Monthly or weekly 7 (20.6) 3 (4.5) 5.53 (1.33–23.00) 0.029 0.135
Consumption of NADs and sharing of equipment 22 (64.7) 25 (37.3) 3.08 (1.30–7.28) 0.012 0.804
Multivariable model summary
Hosmer-Lemeshow-Test (χ-square; p) 6.925 0.226
Nagelkerke's pseudo-R-square 0.327
§

AI = anal intercourse;

§§

BDSM = bondage, dominance/submission, sadism/masochism;

*

UAI = unprotected AI with non-steady partners of unknown HIV serostatus;

**

PDE-5 = phosphodiesterase-5: The risk of penile (rectal) trauma is higher if intercourse is temporally extended by (the partner's) use of PDE-5 inhibitors;

***

NADs = nasally-administered drugs (cocaine, amphetamines, ketamine, etc.);

frequently or always when having sex.